Efficacy and Tolerability of Rimegepant for the Prevention of Migraine in Adults With History of Inadequate Response to Oral Preventive Medications
Clinical trial NCT05518123 · COMPLETED
Trial details
- NCT number
- NCT05518123
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-07
- Primary completion
- 2025-03-31
- Enrollment
- 962
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.